Development
Ekso Bionics Holdings, Inc.
EKSO
$3.14
-$0.11-3.39%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 41.57% | 26.39% | 19.37% | 21.54% | 14.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.57% | 26.39% | 19.37% | 21.54% | 14.81% |
| Cost of Revenue | 37.35% | 32.52% | 32.90% | 44.05% | 48.94% |
| Gross Profit | 46.11% | 20.67% | 7.72% | 4.19% | -7.93% |
| SG&A Expenses | 5.16% | 2.95% | 6.63% | 1.08% | 1.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.29% | 13.65% | 16.32% | 12.69% | 13.54% |
| Operating Income | 2.85% | -2.72% | -13.61% | -5.63% | -12.50% |
| Income Before Tax | -0.78% | -2.69% | -29.65% | -38.59% | -54.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.78% | -2.69% | -29.65% | -38.59% | -54.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.78% | -2.69% | -29.65% | -38.59% | -54.44% |
| EBIT | 2.85% | -2.72% | -13.61% | -5.63% | -12.50% |
| EBITDA | 8.56% | -0.11% | -13.69% | -6.52% | -14.56% |
| EPS Basic | 5.41% | 2.46% | -24.28% | -34.12% | -41.66% |
| Normalized Basic EPS | 5.41% | 2.48% | -24.24% | -21.61% | -28.14% |
| EPS Diluted | 5.08% | 4.98% | -19.10% | -25.69% | -32.54% |
| Normalized Diluted EPS | 5.41% | 2.48% | -24.33% | -21.84% | -28.39% |
| Average Basic Shares Outstanding | 6.96% | 5.46% | 4.34% | 3.33% | 6.35% |
| Average Diluted Shares Outstanding | 6.96% | 5.46% | 4.24% | 3.06% | 6.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |